Why the study?
Are bradykinin receptor gene variants (-58T/C and 1098A/G) associated with an increased risk of hypertension in Chinese populations?
Case-Control (n=976)
Are bradykinin receptor gene variants (-58T/C and 1098A/G) associated with an increased risk of hypertension in Chinese populations?
Odds Ratio: 1.386 (95% CI 1.138–1.688)
p-value: p=0.01
The -58T/C polymorphism in the BDKRB2 gene is significantly associated with an increased risk of hypertension in the Northern Han Chinese population.
BACKGROUND: The present study was to investigate the role of bradykinin receptors genes polymorphisms on hypertension risk in Northern Han Chinese population. We also carried out a meta-analysis on Chinese to derive a more full assessment of this association. METHODS AND RESULTS: A total of 976 subjects from Northern Han Chinese and 7 studies with 1599 cases and 1425 controls were included in this case-control study and in the current meta-analysis, respectively. For the case-control study, we identified the genotypes of -58T/C and 1098A/G polymorphism in BDKRB2 and BDKRB1 genes, respectively, by TaqMan PCR method. Overall, we found significant association between the -58T/C polymorphism and the increased risk of hypertension in the allele comparison (p = 0.01, OR = 1.386, 95% CI [1.138-1.688]). Subgroup analysis by gender suggested that this obvious association could still be found in males, but not in females. For the 1098A/G polymorphism, no significant association was revealed in overall and subgroup analysis. For the meta-analysis involving the -58T/C polymorphism, a significant association between this polymorphism and hypertension was observed in the whole group. In Chinese Han subgroup, we found significant association with hypertension in allele comparison(C vs. T: p = 0.03, OR = 1.28, 95% CI 1.03-1.59, pheterogeneity = 0.05). CONCLUSIONS: Our case-control study indicated that -58T/C might be significantly associated with the increased risk of hypertension in Northern Han Chinese population, which was partially confirmed by our meta-analysis.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2015) conducted a case-control in Hypertension (n=976). -58T/C polymorphism in BDKRB2 gene vs. Reference allele was evaluated on Hypertension (OR 1.386, 95% CI 1.138-1.688, p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: